Annual report [Section 13 and 15(d), not S-K Item 405]

Consolidated Balance Sheets (Parenthetical)

v3.26.1
Consolidated Balance Sheets (Parenthetical) - USD ($)
$ in Thousands
Dec. 31, 2025
Dec. 31, 2024
Investments in marketable securities, amortized cost $ 3,953 $ 2,116
Allowance for doubtful accounts 3 239
Allowance for tax credits receivable current 423 187
Allowance for tax credits receivable noncurrent $ 0 $ 421
Preferred stock, shares authorized 10,000,000 10,000,000
Preferred stock, shares issued 0 0
Preferred stock, shares outstanding 0 0
Common stock, par value $ 0.001 $ 0.001
Common stock, shares authorized 190,000,000 190,000,000
Common stock, shares issued 55,282,150 46,285,078
Common stock, shares outstanding 54,857,000 46,209,081
Treasury Stock, Common [Member]    
Treasury stock, shares 425,150 75,997
Series A Preferred Stock [Member]    
Preferred stock, shares authorized 6,000 6,000
Preferred stock, shares issued 0 0
Preferred stock, shares outstanding 0 0
Preferred stock, par value $ 0.001 $ 0.001
Series B Preferred Stock [Member]    
Preferred stock, shares authorized 0 0
Preferred stock, shares issued 0 0
Preferred stock, shares outstanding 0 0
Preferred stock, par value $ 0.001 $ 0.001
Series C Preferred Stock [Member]    
Preferred stock, shares authorized 50,000 50,000
Preferred stock, shares issued 0 0
Preferred stock, shares outstanding 0 0
Preferred stock, par value $ 0.001 $ 0.001